BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24920768)

  • 1. Assessment of ambiguous base calls in HIV-1 pol population sequences as a biomarker for identification of recent infections in HIV-1 incidence studies.
    Meixenberger K; Hauser A; Jansen K; Yousef KP; Fiedler S; von Kleist M; Norley S; Somogyi S; Hamouda O; Bannert N; Bartmeyer B; Kücherer C
    J Clin Microbiol; 2014 Aug; 52(8):2977-83. PubMed ID: 24920768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence ambiguity determined from routine pol sequencing is a reliable tool for real-time surveillance of HIV incidence trends.
    Lunar MM; Židovec Lepej S; Poljak M
    Infect Genet Evol; 2019 Apr; 69():146-152. PubMed ID: 30682549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, estimated HIV-1 incidence and viral diversity among people seeking voluntary counseling and testing services in Rio de Janeiro, Brazil.
    de Castro CA; Grinsztejn B; Veloso VG; Bastos FI; Pilotto JH; Morgado MG
    BMC Infect Dis; 2010 Jul; 10():224. PubMed ID: 20667113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance of HIV type 1 recent infection and molecular epidemiology among different risk behaviors between 2007 and 2009 after the HIV type 1 CRF07_BC outbreak in Taiwan.
    Kao CF; Chang SY; Hsia KT; Chang FY; Yang CH; Liu HR; Fu TY; Yang JY
    AIDS Res Hum Retroviruses; 2011 Jul; 27(7):745-9. PubMed ID: 21235402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Recency Period for Estimation of Human Immunodeficiency Virus Incidence by the AxSYM Avidity Assay and BED-Capture Enzyme Immunoassay in the Republic of Korea.
    Yu HK; Heo TY; Kim NY; Wang JS; Lee JK; Kim SS; Kee MK
    Osong Public Health Res Perspect; 2014 Aug; 5(4):187-92. PubMed ID: 25379368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of sequence ambiguities of the HIV-1 pol gene as a method to identify recent HIV-1 infection in transmitted drug resistance surveys.
    Andersson E; Shao W; Bontell I; Cham F; Cuong do D; Wondwossen A; Morris L; Hunt G; Sönnerborg A; Bertagnolio S; Maldarelli F; Jordan MR
    Infect Genet Evol; 2013 Aug; 18():125-31. PubMed ID: 23583545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with incorrect identification of recent HIV infection using the BED capture immunoassay.
    Laeyendecker O; Brookmeyer R; Oliver AE; Mullis CE; Eaton KP; Mueller AC; Jacobson LP; Margolick JB; Brown J; Rinaldo CR; Quinn TC; Eshleman SH;
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):816-22. PubMed ID: 22014036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV incidence determination in the United States: a multiassay approach.
    Laeyendecker O; Brookmeyer R; Cousins MM; Mullis CE; Konikoff J; Donnell D; Celum C; Buchbinder SP; Seage GR; Kirk GD; Mehta SH; Astemborski J; Jacobson LP; Margolick JB; Brown J; Quinn TC; Eshleman SH
    J Infect Dis; 2013 Jan; 207(2):232-9. PubMed ID: 23129760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV diversity as a biomarker for HIV incidence estimation: including a high-resolution melting diversity assay in a multiassay algorithm.
    Cousins MM; Konikoff J; Laeyendecker O; Celum C; Buchbinder SP; Seage GR; Kirk GD; Moore RD; Mehta SH; Margolick JB; Brown J; Mayer KH; Koblin BA; Wheeler D; Justman JE; Hodder SL; Quinn TC; Brookmeyer R; Eshleman SH
    J Clin Microbiol; 2014 Jan; 52(1):115-21. PubMed ID: 24153134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 mother-to-child transmission and drug resistance among Brazilian pregnant women with high access to diagnosis and prophylactic measures.
    Alcântara KC; Lins JB; Albuquerque M; Aires LM; Cardoso LP; Minuzzi AL; Stefani MM
    J Clin Virol; 2012 May; 54(1):15-20. PubMed ID: 22317908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved testing of recent HIV-1 infections with the BioRad avidity assay compared to the limiting antigen avidity assay and BED Capture enzyme immunoassay: evaluation using reference sample panels from the German Seroconverter Cohort.
    Hauser A; Santos-Hoevener C; Meixenberger K; Zimmermann R; Somogyi S; Fiedler S; Hofmann A; Bartmeyer B; Jansen K; Hamouda O; Bannert N; Kuecherer C
    PLoS One; 2014; 9(6):e98038. PubMed ID: 24892795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incident and long-term HIV-1 infection among pregnant women in Brazil: Transmitted drug resistance and mother-to-child transmission.
    Lima YA; Cardoso LP; Reis MN; Stefani MM
    J Med Virol; 2016 Nov; 88(11):1936-43. PubMed ID: 27037910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of HIV-1 ambiguous nucleotide frequency during antiretroviral treatment interruption.
    Li JZ; Christensen JA; Wang H; Spritzler J; Kuritzkes DR;
    J Acquir Immune Defic Syndr; 2012 Sep; 61(1):19-22. PubMed ID: 22732468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimated incidence and genotypes of HIV-1 among pregnant women in central Brazil.
    Costa ZB; Stefani MM; de Lima YA; de Souza WV; de Siqueira Filha NT; Turchi MD; Borges WC; Filho CG; Filho JV; Minuzzi AL; Martelli CM
    PLoS One; 2013; 8(11):e79189. PubMed ID: 24223904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection.
    Kouyos RD; von Wyl V; Yerly S; Böni J; Rieder P; Joos B; Taffé P; Shah C; Bürgisser P; Klimkait T; Weber R; Hirschel B; Cavassini M; Rauch A; Battegay M; Vernazza PL; Bernasconi E; Ledergerber B; Bonhoeffer S; Günthard HF;
    Clin Infect Dis; 2011 Feb; 52(4):532-9. PubMed ID: 21220770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of unusual and signature APOBEC-mutations in HIV-1 pol next-generation sequences.
    Tzou PL; Kosakovsky Pond SL; Avila-Rios S; Holmes SP; Kantor R; Shafer RW
    PLoS One; 2020; 15(2):e0225352. PubMed ID: 32102090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino Acid Prevalence of HIV-1
    Tzou PL; Rhee SY; Shafer RW
    AIDS Res Hum Retroviruses; 2019 Oct; 35(10):924-929. PubMed ID: 31317771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya.
    Onywera H; Maman D; Inzaule S; Auma E; Were K; Fredrick H; Owiti P; Opollo V; Etard JF; Mukui I; Kim AA; Zeh C
    PLoS One; 2017; 12(2):e0171124. PubMed ID: 28178281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of low HIV type 1 load and antiretroviral treatment on IgG-capture BED-enzyme immunoassay.
    Hayashida T; Gatanaga H; Tanuma J; Oka S
    AIDS Res Hum Retroviruses; 2008 Mar; 24(3):495-8. PubMed ID: 18327979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An increasing proportion of monotypic HIV-1 DNA sequences during antiretroviral treatment suggests proliferation of HIV-infected cells.
    Wagner TA; McKernan JL; Tobin NH; Tapia KA; Mullins JI; Frenkel LM
    J Virol; 2013 Feb; 87(3):1770-8. PubMed ID: 23175380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.